Answers are grounded in this paper and cite their sources.
The penis contains 3 long cylindrical tubes of tissue: the corpus spongiosum and dorsally a pair of corpus cavernosum (CC) (Figure 1A). The CC is contained within a tough outer covering known as the tunica albuginea and consists of an interconnected network of sinusoidal spaces surrounded by the corpus cavernosum smooth muscle (CCSM) (Figure 1B). In the flaccid (nonerect) state, the CCSM is contracted and arterial inflow is minimal. Penile erection (tumescence) is a complex neurophysiological process which results from an increase in intracavernous pressure (ICP) being attained within the CC of the penis. Basically, in response to neuronal stimulation, the arteries that supply the penis and the CCSM relax, increasing blood flow to the sinusoids. Expansion of the sinusoids compresses the venular plexuses, thus reducing venous outflow. As a result, CC ICP increases until full erection is achieved at about 100 mm Hg. Thus, the CCSM, unlike most other smooth muscle (SM), spends the majority of its time in the contracted state and relaxes only upon receiving erectogenic stimuli. Effective treatment of erectile dysfunction (ED) requires the development of therapeutic agents that affect the contraction and relaxation of the CCSM. A better understanding of the molecular mechanisms that regulate contraction in the CCSM is critical to achieve this effect. This review examines the role that the CCSM plays in both normal erectile function as well as in ED. Special emphasis is placed on the role of SM myosin (SMM) and the endothelin/Rho-kinase (ET/ROK) pathway in modulating CCSM tone, including the role sex hormones are known to play in this regulation. Molecular mechanisms of SM relaxation, though certainly important in regulating the SM tone of the CCSM, will not be examined in detail in this review because they have been covered in other reviews in this issue. . (Panel A) Schematic drawing of a cross-section through the body of the penis, with major structures labeled. (Panel B) Schematic drawing of the major structures located within a single corpus cavernosum in the flaccid (nonerect) state of the penis. During flaccidity, blood flows freely into the cavernosal spaces, and the deoxygenated blood is constantly removed by the venules. In response to erectogenic stimuli, the smooth muscle lining both the arteries and the sinusoidal spaces relaxes, allowing even more blood to flow into the cavernosal spaces, which causes them to swell and eventually some press against the emissary veins, decreasing outflow and leading to the rise in intracavernosal pressure necessary for erection. The CCSM, unlike most other SMs, remains contracted the majority of the time and then relaxes to carry out its physiological function (erection). Unlike skeletal and cardiac muscle, which are regulated by calcium through a tropomyosin-troponin complex, the initiation of contraction in all SM involves a phosphorylation-dephosphorylation pathway that was originally thought to be activated only by an elevation of cytosolic calcium [Ca2+]I (Adelstein and Eisenberg, 1980). An increase in [Ca2+]I activates a Ca2+-calmodulin-dependent myosin light chain kinase (MLCK) which phosphorylates the 20-kDa regulatory light chain of SMM (see Figure 2B) at Ser19 and shows a direct correlation with an increase in actin-activated ATP hydrolysis and associated cross-bridge cycling needed for generation of force (Gorecka et al, 1976; Chacko et al, 1977; Sobieszek and Small, 1977; Hai and Murphy, 1988). The level of cytosolic calcium then returns to resting levels which inactivates MLCK, and then the myosin is dephosphorylated by SMM phosphatase (SMMP) (Hartshorne et al, 1998), leading to SM relaxation (for summary, see Figure 3, lower right quadrant). . (Panel A) Schematic drawing showing 1 head of a single myosin molecule protruding from the thick filament and making contact with an actin molecule in the thin filament. (Panel B) Close-up of a single myosin molecule showing the approximate locations of the essential 17-kDa light chain (MLC17) pair and the 20-kDa phosphorylatable light chain pair (MLC20). In addition, the locations of the SM-A/SM-B and SM1/SM2 alternative spice regions, as well as the region of the myosin molecule which binds to actin (actin binding) and the catalytic site for ATP (ATP pocket), are shown on the 2 globular heads of the myosin molecule. . Schematic drawing depicting the major participants in the endothelin/Rho-kinase pathway of corpus cavernosum smooth muscle (CCSM) contraction. Pathways leading to CCSM contraction, and hence penile flaccidity, are indicated by solid lines, and pathways leading to CCSM relaxation and penile erection are indicated by dashed lines. The double lines indicate an inhibitory effect on that pathway. Modified from Somlyo et al (1997). Thus, treatment of ED requires the development of therapeutic agents that affect the contraction and relaxation of the CCSM. A better understanding of the molecular mechanisms that regulate contraction in the CCSM is critical to achieve this. Indeed, it has been found that even if the primary site of damage is neurogenic or vasculogenic in origin, normal erectile function can be achieved as long as sufficient SM relaxation is restored (Christ, 1995). The ability of SM to contract has been shown to be dependent upon the interaction between the major contractile proteins, actin and myosin (Figure 2A). A sliding filament model, described in detail for striated muscle contraction (Adelstein and Eisenberg, 1980; Chacko and Longhurst, 1995), also applies to SM, although the contractile apparatus in SM is not as highly ordered as in striated muscle. In addition to the level of phosphorylation of SMM, the myosin isoform composition can also influence the contractility of SM. Myosin II is the molecular motor for contraction in all types of muscles. In general, the velocity of force generation by a muscle is determined by the ATPase activity of the myosin II when it interacts with actin (Barany, 1967). SMM is a type II myosin that is composed of a pair of myosin heavy chains (MHCs) and 2 pairs of myosin light chains (MLCs) (Figure 2B). The MHCs wrap around each other to form an α-helical carboxyl-terminal tail and 2 amino-terminal globular heads. Each head contains an actin-binding site and an active site for ATP hydrolysis needed to drive the myosin head along the actin filament to produce force (Adelstein and Eisenberg, 1980) (Figure 2B). Unlike skeletal or cardiac myosin in which different myosin isoforms are generally encoded by different genes, the mRNAs which encode the 4 vertebrate SMM heavy chain (SMMHC) isoforms identified to date originate from a single SMMHC gene through 2 alternative splice mechanisms (Figure 4). Two SMMHC isoforms, SM1 (204 kDa) and SM2 (200 kDa), which are different at the C-terminal region, are formed by alternative splicing at the 3′ end (Babij and Periasamy, 1989). A recent study shows that increasing the SM1:SM2 ratio in SM has a significant effect on contractile function (Pyne et al, 2002), possibly by stabilizing the thick filament through tail-region interaction with the head of an adjacent myosin molecule (Rovner et al, 2002). . Schematic drawing showing the regions of the SMMHC proteins that differ between the SM-A/SM-B and the SM1/SM2 isoforms (upper Panel) and the regions of SMM essential light chain proteins that differ between the LC17a/LC17b isoforms (lower Panel) as a result of alternative splicing of the respective pre-mRNA. Alternative splicing at the 5′ end of the pre-mRNA also produces 2 SMMHC isoforms, SM-A and SM-B, which are different at the N-terminal region (Babij et al, 1991) (Figure 4). The SM-B isoform contains a 7 amino-acid insert near the ATP-binding site (encoded by a 21-nt insert in the mRNA), and this insert is absent in the SM-A isoform (Babij, 1993; Kelley et al, 1993). The presence of SM-B correlates with increased actin-activated Mg2+-ATPase activity, increased velocity of movement of actin filaments in vitro, and increased maximum velocity of SM shortening compared with aortic SMM, which completely lacks this insert (Kelley et al, 1993; DiSanto et al, 1997; Babu et al, 2001). In general, more SM-B is found in SMs that show a strong phasic-like response to stimulation (eg, urinary bladder and esophageal body), whereas greater amounts of SM-A are present in SMs that are more tonic-like (eg, aortic and lower esophageal sphincter) (Kelley et al, 1993; DiSanto et al, 1997; Szymanski et al, 1998; Hypolite et al, 2001). The rabbit and human CCSM contain an intermediate percentage of SM-B (about 35%) (DiSanto et al, 1998b). We have found that the amount of SM-B is decreased to virtually zero in men diagnosed with ED (DiSanto et al, 1998a). One of the pairs of MLCs, known as the essential light chains, also exist as 2 different isoforms generated via alternative splicing of a single gene (Nabeshima et al, 1987; Lenz et al, 1989). These 2 isoforms, known as LC17a and LC17b, are identical except for 5 of the last 9 carboxyl-terminal amino acids (Hasegawa et al, 1988). Because a greater ratio of LC17b to LC17a is found in tonic-type muscles than in more phasic muscles, it has been proposed that the LC17a/LC17b isoform composition in a particular SM may help determine its tonicity (Helper et al, 1988; Malmqvist and Arner, 1991). Our laboratory has found that rabbit CCSM contains about 13% LC17b and thus 87% LC17a (DiSanto et al, 1998b) compared with the phasic-type normal rabbit bladder that expresses almost 100% LC17a and the tonic-type normal rabbit aorta which expresses almost equal amounts of LC17a and LC17b. More recently, it has been shown that SM contraction can also occur even in the absence of changes in [Ca2+]I by inhibiting SMMP (Somlyo et al, 1989; Kitazawa et al, 1991) via a guanine nucleotide-binding protein (G protein)-coupled mechanism. This process has been termed calcium sensitization of SM because inhibiting the SMMP does not require calcium and allows the MLCK to work more efficiently, leading ultimately to increased force. RhoA, a member of the Rho subfamily of Ras proteins, becomes active when bound to guanosine triphosphate (GTP) and activates an enzyme known as ROK (Matsui et al, 1996). Activated ROK has been proposed to increase the phosphorylation level of SMM either by directly phosphorylating the myosin (Amano et al, 1996) or indirectly by inhibiting the phosphatase responsible for dephosphorylating SMM (Kimura et al, 1996). Thus, ROK activity is regulated through a complex molecular pathway, the participants of which are just starting to be identified. A brief summary of the major participants in this pathway and how these pathways are thought to interact is shown in Figure 3. ROK has been classified into 2 isoforms: ROKα and ROKβ, also referred to as ROCK-II and ROCK-I, respectively (Nakagawa et al, 1996). These isoforms are relatively large proteins (150–160 kDa) consisting of an amino-terminal kinase domain, a central coiled-coil domain that includes a Rho-binding domain, and a carboxyl-terminal putative pleckstrin homology domain. Although the kinase domain is more than 90% conserved between ROKα and ROKβ in the mouse, the rest of the molecules are only around 55% to 70% conserved, suggesting that the 2 enzymes may have somewhat different cellular functions (Nakagawa et al, 1996). Although data have shown that both rabbit and human CCSM express both isoforms of ROK (Chang et al, 2000; Wang et al, 2002), in certain pathological conditions such as diabetes (Chang et al, 2002a) and partial bladder outlet obstruction (Chang et al, 2002b), expression of the ROKβ isoform in the CCSM appears to be altered more than does expression of the ROKα isoform, at least in the rabbit. The inhibitor Y-27632, a selective inhibitor of ROK (Uehata et al, 1997), has been shown to have little effect on the initial transient increase in force in the coronary artery, but it nearly abolished the sustainment of force in this muscle (Nobe and Paul, 2001). Thus, along with confirming a role for ROK in calcium sensitization of SM, the above study suggests that ROK should play a major role in keeping the CCSM in the flaccid (tonically contracted) state. Using permeabilized CCSM strips in which calcium concentrations were clamped, Wang et al (2002) found that the GTPγS-induced Ca2+-sensitization in CCSM was 2 times higher than that reported for other SMs, again suggesting an important role for RhoA/ROK in CCSM contraction. Chitaley et al (2001) demonstrated the in vivo importance of ROK to CCSM tone when they showed that administration of the ROK inhibitor Y-27632 to normal rats resulted in penile erection. Chitaley and Webb (2002) suggested that the mechanism by which nitric oxide (NO) causes vascular SM relaxation involves inhibition of ROK signaling. The mechanistic link between these 2 pathways appears to be the enzyme known as cyclic guanosine monophospate (cGMP)-dependent protein kinase-1 (PKG-1), which will be discussed in more detail in the following section. An increased production of NO is known to increase the levels of cGMP and hence activate PKG-1. Because PKG-1 has been shown to phosphorylate RhoA, thus inhibiting its ROK activating ability (Sawada et al, 2001), an increase in NO can lead to inactivation of the ROK pathway (see PKG in schematic of Figure 3—double green arrow indicates blocking RhoA translocation to membrane by phosphorylation). cGMP appears to be the main mediator of relaxation in the CCSM. In response to sexual stimuli, release of NO from causes elevation of cGMP via stimulation of activity, which then to relaxation of the CCSM and eventually to penile erection. 5 can cGMP to and it is this that is and by such as and the mechanism by which cGMP causes CCSM relaxation remains although the pathway is proposed to of PKG-1 et al, 1995). The physiological of the PKG-1 enzyme in SM has been demonstrated by out the PKG-1 gene in These have been shown to completely SM relaxation and et al, More to this review is that these PKG-1 have a ability to which appears to be the result of the of CCSM to upon of the pathway et al, protein or are classified into 2 and on of In general, is membrane whereas is found in the of the are 2 isoforms, kDa) and kDa), which from the alternative splicing of a single gene et al, 1988; et al, 1989). These 2 isoforms differ in amino-terminal but are identical in and catalytic is highly in the of the in in and in SM whereas the isoform is in SM et al, and Our laboratory has shown that the expression of is in CCSM in response to diabetes and that this decreased expression correlates with a of in PKG activity (Chang et al, The are a of amino-acid consisting of and et al, each the of a gene and from by only a amino acids and The expression of the isoforms in different with being the in normal et al, and proposed to play the role in regulating CCSM have suggested that plays an important role as a of erectile and dysfunction et al, et al, 1995). Although are a major of vascular SM et al, et al, as well as the CCSM et al, et al, can also produce Thus, can be from the either lining the arteries within the CC or lining the CCSM and also directly from the CCSM the level of by vascular SM is in including and et al, et al, 2001). The of to be by 2 main of which are referred to as and and are encoded by et al, et al, 1991). of the has been shown to a transient et al, whereas of either the or the can a contraction of SM et al, Thus, the expression of these may be for the contractile state of the CCSM. Although both and exist in CCSM et al, 1995), including human et al, 1995), from the CCSM contraction appears to be by Our work has shown that in response to the of the CCSM to is increased and the mechanism for this increase appears to an of the (Chang et al, 2002a) (Figure This of an of expression in response to diabetes is also by a study that found increased by in rats with diabetes compared with normal rats et al, 1995). Our that contraction of CCSM can be almost completely by with the ROK inhibitor Y-27632 (Chang et al, 2002a) suggests that contraction in CCSM is dependent upon the ROK pathway. . of and amounts of protein from 2 each from normal and were a by and then to membrane and with to (Panel A) or (Panel The each with of the from the with from et al, Although have shown that decreased levels are associated with of and ED in et al, Wang et al, these changes have been thought to be than a direct effect on human CCSM 2002). in is that suggests that levels can directly affect the contractility of the CCSM. it was determined that affect the of SM to in as as resulted in a in the ICP achieved erection et al, this study determined that the of the SM be to normal levels by administration of These results were by a study that showed that resulted in an increased of in response to in a and The that in rats is associated with a in both levels and erectile function and normal erectile can be restored with administration of et al, also a role for in erectile the SM of the penis contains and it has been that it may be to the erectile process because SM in the penis is also an in the of in the penile SM but not in the penile or Thus, does to have a direct effect on the penile has been demonstrated that the CCSM from increased contraction to et al, whereas relaxation of CCSM from by stimulation or et al, 1996) is compared with CCSM from rats has been found to be more to either by or by cGMP compared with et al, in of has been shown to increase CCSM relaxation by stimulation et al, 2002), et al, and et al, Although a correlation between level and NO expression in the has been et al, 1997; et al, 1997; et al, 1997; et al, et al, et al, the of altered CCSM contractility is not The following 2 to that changes in the CCSM contractile apparatus may play a role in of CCSM has been shown that the SM of the CC in and that can normal SM et al, Our laboratory has suggesting that decreasing sex hormones SMM Using a rabbit model, showed that expression of bladder SMM was decreased in and this be by administration of et al, 2001). showed in this study that the ratio of the SMMHC isoform composition was decreased may the thick filament leading to increased contractility as described and be to normal by levels (Figure have also been the expression of SMM in the was shown to et al, 2001), but the isoform composition has not been Because the in this study were shown to have a decreased expression of levels it is suggested that decreased as well as levels can SMM . SMMHC isoform protein expression in rabbit bladder smooth muscle. (Panel A) of protein from urinary bladder smooth muscle, a highly 1 to 3 to normal and SM1 and SM2 were and by (Panel B) of smooth muscle myosin SM1/SM2 by an against and of protein expression and as determined by of the in A in and protein in the 3 and with from et al, the above is the that and as well as have been shown to increase the expression of SMM in human SM et al, 1997; et al, 2001). have been In the but not the decreased expression of SM1 and increased the expression of known as SM-B whereas but not the expression et al, 1995). it has been demonstrated in rats that and that administration of to these in including the this is the SM may an altered myosin isoform Although link between sex levels and the RhoA/ROK pathway has been are some which a link between RhoA/ROK activity and of RhoA has been demonstrated to whereas of active of RhoA results in decreased activity et al, 2001). activity can be by the RhoA protein kinase et al, In addition, stimulation of the Rho pathway has been shown to activate et al, 2002). the between the RhoA/ROK pathway and in the CCSM direct of on PKG have been coronary SM from normal rats more in response to the PKG than arteries from suggesting a decreased amount or activity of PKG in the et al, 1996). coronary SM from rats more to than arteries from rats et al, 1996). either by or in with has been shown to PKG activity et al, Although these were originally thought to be through of activated et al, 1995), the more recent of a role for PKG in the ROK pathway may a role for in the direct of the SM contractile The that can direct relaxation of arterial SM et al, et al, 1996) suggests that may also have an effect on of rats was associated with a to increase in the expression of suggesting a role for in regulating expression et al, 2002). This study also found an increase in as well as again a role for in regulating the pathway of contraction. an increased expression of in has been et al, 2002). Indeed, appears to have an effect on CCSM contractility as in by the decreased the ability of from with on to rabbit CCSM, whereas to the with not only restored but the CCSM ability of et al, 2002). Although these that the mechanism by which decreased levels relaxation by is through a of NO it is also that the decreased levels may expression of the or as has been shown for the thus making it for to CCSM. diabetes in rats also causes an of and it was found that levels were in these et al, 1996). This suggests that of increased CCSM to through an of in with diabetes compared with normal at least result from a in levels associated with the Thus, the expression of and in the CCSM of and will be to along with the of The of the CCSM is necessary for the normal erectile As in this are molecular mechanisms that function at the level of the SM and are of regulating CCSM These mechanisms phosphorylation of the SMM, of SMM isoform and in the expression of participants in the calcium sensitization pathways of SM contraction, including the pathway. these molecular mechanisms as well as the influence that hormones have on these pathways should and for development to ED.
No takes yet. Share an insight, caveat, or question.
Michael E. DiSanto (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: